Arcadia Biosciences, Inc. (RKDA)
0.1648
-0.04
(-19.02%)
USD |
NASDAQ |
Oct 16, 16:00
0.1594
-0.01
(-3.28%)
After-Hours: 20:00
Arcadia Biosciences EPS Diluted (Quarterly) : -2.094 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.094 |
| March 31, 2026 | -2.105 |
| December 31, 2025 | -0.9759 |
| September 30, 2025 | 0.624 |
| June 30, 2025 | -3.261 |
| March 31, 2025 | 1.902 |
| December 31, 2024 | -2.977 |
| September 30, 2024 | -1.182 |
| June 30, 2024 | 0.7785 |
| March 31, 2024 | -1.779 |
| December 31, 2023 | -2.220 |
| September 30, 2023 | -1.888 |
| June 30, 2023 | 0.6059 |
| March 31, 2023 | -10.86 |
| December 31, 2022 | -6.889 |
| September 30, 2022 | -4.671 |
| June 30, 2022 | -6.809 |
| March 31, 2022 | -8.091 |
| December 31, 2021 | -16.74 |
| September 30, 2021 | -3.923 |
| June 30, 2021 | -9.678 |
| March 31, 2021 | 4.323 |
| December 31, 2020 | 26.46 |
| September 30, 2020 | -23.85 |
| Date | Value |
|---|---|
| June 30, 2020 | -41.55 |
| March 31, 2020 | 11.64 |
| December 31, 2019 | -28.88 |
| September 30, 2019 | -81.74 |
| June 30, 2019 | 33.54 |
| March 31, 2019 | -105.62 |
| December 31, 2018 | -5.412 |
| September 30, 2018 | 37.28 |
| June 30, 2018 | -80.65 |
| March 31, 2018 | -194.22 |
| December 31, 2017 | -55.48 |
| September 30, 2017 | -84.82 |
| June 30, 2017 | -75.11 |
| March 31, 2017 | -76.03 |
| December 31, 2016 | -104.00 |
| September 30, 2016 | -72.00 |
| June 30, 2016 | -80.00 |
| March 31, 2016 | -96.00 |
| December 31, 2015 | -72.00 |
| September 30, 2015 | -88.00 |
| June 30, 2015 | -152.00 |
| March 31, 2015 | -2968.00 |
| December 31, 2014 | -352.00 |
| December 31, 2013 | -51.76 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -0.1235 |
| PMGC Holdings, Inc. | -60.32 |
| Archer-Daniels-Midland Co. | 1.872 |
| Alico, Inc. | 0.2857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.266M |
| Revenue (Quarterly) | 1.443M |
| Total Expenses (Quarterly) | 7.709M |
| Enterprise Value | -3.818M |
| Gross Profit Margin (Quarterly) | 43.73% |
| Profit Margin (Quarterly) | -434.2% |
| Earnings Yield | -2.76K% |
| Normalized Earnings Yield | -2238.65 |